MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2026: Is biotech back? Four drugmakers go public, raising $1 billion total
AgomAb Therapeutics NV(AGMB)
Finance & Acquisitions: AgomAb Therapeutics
2021: AgomAb raises $74M to develop regenerative pathway modulators
Regenerative pathway modulators in inflammatory, metabolic and fibrotic diseases.
Parents
2021: AgomAb raises $74M to develop regenerative pathway modulators
Organization & Developments: AgomAb Therapeutics